Who is the R&D manufacturer of Trientine?

Trientine(Trientine) is an oral copper chelator, mainly used to treat Wilson's disease (rare disease), that is, hepatolenticular degeneration. Wilson's disease is a metabolic disorder caused by a genetic defect. The patient's body cannot excrete copper ions normally, causing copper to accumulate in organs such as the liver, brain, and kidneys, which in turn causes a variety of serious symptoms. Trientine promotes the excretion of copper by binding to copper ions in the body, thereby effectively reducing copper accumulation and alleviating the patient's symptoms.

The original manufacturer of trientine isUnivar Solutions BV. Founded in 1960, Univar Solutions is one of the world's leading chemical distributors and service providers, providing supply chain solutions including pharmaceuticals, chemicals, and products for a variety of other industries. The company is committed to providing high-quality products and services to the global pharmaceutical, chemical and food industries through advanced technology, extensive supply chain and global network. As one of the representative drugs of Univar Solutions, trientine plays an important role in the treatment of Wilson's disease, especially for those patients who cannot tolerate D-penicillamine.

The R&D and marketing of trientine reflectUnivar Solutions’ in-depth presence in the pharmaceutical field. Through close cooperation with pharmaceutical companies and scientific research institutions, the company not only ensures the effectiveness and safety of the drug, but also makes trientine available in many countries through global distribution channels and serves a large number of patients in need of the drug. The introduction of trientine provides an alternative treatment option for patients with Wilson's disease, especially those who have adverse reactions or poor tolerance to penicillamine.

In general, Trientine's R&D companyUnivar Solutions BV has provided a key treatment method for patients with Wilson's disease through years of R&D accumulation and continues to play an important role in the global drug market.

Keyword tags: Trientine,Wilson's disease, hepatolenticular degeneration, Univar Solutions BV, copper chelator, original drug, D-penicillamine

Reference materials:https://www.medicines.org.uk/emc/product/100003/smpc